Skip to main content
High RiskFDAfda-F-0327-2020UNDECLARED ALLERGEN

House Foods Chinese Mabo Tofu Sauce, mild; NET WT. 5.29 oz. (150 g) 4 servings UPC: 0 77377 74064 8 Ingredients: Water, Tomato Pa...

Category
Units Affected
23,430
Recall Date
November 1, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0327-2020.

Reports of weak seal on pouch that may cause leaking and potential for growth of microorganisms.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0327-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact House Foods America Corporation or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0327-2020.

House Foods America Corporation

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

House Foods America Corporation Recall FAQ

House Foods America Corporation is the subject of a beverages safety report: House Foods Chinese Mabo Tofu Sauce, mild; NET WT. 5.29 oz. (150 g) 4 servings UPC: 0 77377 74064 8 Ingredients: Water, Tomato Pa.... The notice was published on November 1, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 23,430 units are potentially affected.